Health economics in the field of osteoarthritis

Funding Information: M.H. (Mickael Hiligsmann) has received research grant, lecture fees, and/or consulting fees from Amgen, Pfizer, Novartis, Servier, and SMB. C.C. has received honoraria and consulting fees from AMGEN, GSK, Alliance for Better Bone Health, MSD, Eli Lilly, Pfizer, Novartis, Servier...

ver descrição completa

Detalhes bibliográficos
Autor principal: Hiligsmann, Mickaël (author)
Outros Autores: Cooper, Cyrus (author), Arden, Nigel (author), Boers, Maarten (author), Branco, Jaime C. (author), Luisa Brandi, Maria (author), Bruyère, Olivier (author), Guillemin, Francis (author), Hochberg, Marc C. (author), Hunter, David J. (author), Kanis, John A. (author), Kvien, Tore K. (author), Laslop, Andrea (author), Pelletier, Jean Pierre (author), Pinto, Daniel (author), Reiter-Niesert, Susanne (author), Rizzoli, René (author), Rovati, Lucio C. (author), Severens, Johan L.Hans (author), Silverman, Stuart (author), Tsouderos, Yannis (author), Tugwell, Peter (author), Reginster, Jean Yves (author)
Formato: article
Idioma:eng
Publicado em: 2022
Assuntos:
Arthroplasty
Cost-effectiveness
Cost-utility
Economics
Methods
Osteoarthritis
Review
Rheumatology
Anesthesiology and Pain Medicine
Texto completo:http://hdl.handle.net/10362/145602
País:Portugal
Oai:oai:run.unl.pt:10362/145602

Texto Completo

http://hdl.handle.net/10362/145602

Registros relacionados